Protective Antibodies Develop, and Murine Lyme Arthritis Regresses, in the Absence of MHC Class II and CD4+ T Cells

Journal of Immunology

Volumn 159, Issue 11, 1997, Pages 5682-5686

  Fikrig, Erol ^a   Barthold, Stephen W ^a   Chen, Manchuan ^a   Chang, Cheong Hee ^a,b   Flavell, Richard A ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; HLA ANTIGEN CLASS 2;

ANIMAL; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; BIOSYNTHESIS; BORRELIA BURGDORFERI; C3H MOUSE; CD4+ T LYMPHOCYTE; FEMALE; IMMUNIZATION; IMMUNOLOGY; INFECTIOUS ARTHRITIS; LYME DISEASE; MOUSE; MOUSE MUTANT;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY-DEPENDENT CELL CYTOTOXICITY; ARTHRITIS, INFECTIOUS; BORRELIA BURGDORFERI GROUP; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNIZATION; LYME DISEASE; MICE; MICE, INBRED C3H; MICE, SCID;

EID: 0031303476     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Barthold, S. W., M. S. deSouza, J. L. Janotka, A. L. Smith, and D. H. Persing. 1993. Chronic Lyme borreliosis in the laboratory mouse. Am. J. Pathol. 143:959.
2. Barthold, S. W., D. H. Persing, A. L. Armstrong, and R. A. Peeples. 1991. Kinetics of Borrelia burgdorferi: dissemination and evolution of disease following intradermal inoculation of mice. Am. J. Pathol. 163:263.
3. Barthold, S., M. d. Souza, and S. Feng. 1996. Serum-mediated resolution of Lyme arthritis in mice. Lab. Invest. 74:57.
4. Barthold, S. W., C. L. Sidman, and A. L. Smith. 1992. Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am. J. Trop. Med. Hyg. 47:605.
5. Schaible, U., M. Kramer, C. Museteanu, H. Zimmer, H. Mossman, and M. M. Simon. 1989. The severe combined immunodeficient mouse: a laboratory model of Lyme arthritis and carditis. J. Exp. Med. 170:240.
6. Schaible, U. E., S. Gay, C. Museteanu, M. D. Kramer, G. Zimmer, K. Eichmann, U. Museteanu, and M. M. Simon. 1990. Lyme borreliosis in the severe combined immunodeficiency (seid) mouse manifests predominantly in the joints, heart, and liver. Am. J. Pathol. 137:811.
7. Barthold, S. W., S. Feng, L. K. Bockenstedt, E. Fikrig, and K. Feen. 1997. Protective and arthritis-resolving activity in serum of mice actively infected with Borrelia burgdorferi. Clin. Infect. Dis. 25:59.
8. Schaible, U. E., R. Wallich, M. D. Kramer, G. Nerz, T. Stehle, C. Museteanu, and M. M. Simon. 1994. Protection against Borrelia burgdorferi infection in seid mice is conferred by presensitized spleen cells and partially by B but not T cells alone. Int. Immunol. 6:671.
9. Fikrig, E., S. Barthold, M. Chen, I. Grewal, and R. Flavell. 1996. Protective antibodies in Lyme disease arise independently of CD40 ligand. J. Immunol. 157:1.
10. Fikrig, E., S. W. Barthold, W. Sun, W. Feng, S. R. Telford, and R. A. Flavell. 1997. Borrelia burgdorferi P35 and P37, selectively induced in vivo, elicit protective immunity. Immunity 6:531.
11. Frey, A.B., and T. D. Rao. 1995. Single exposure of mice to Borrelia burgdorferi elicits immunoglobulin G antibodies characteristic of secondary immune response without production of interleukin-4 by immune T cells. Infect. Immun. 63:2596.
12. Keane-Myers, A., and S. P. Nickell. 1995. T cell subset-dependent modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 154:1770.
13. + Th2 T cells elicited by immunization confer protective immunity to experimental Borrelia burgdorferi infection. Ann. NY Acad. Sci. 730:364.
14. + T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters. Infect. Immun. 63:4818.
15. Lim, L. C., D. M. England, B. K. DuChateau, N. J. Glowacki, and R. F. Schell. 1995. Borrelia burgdorferi-specitic T lymphocytes induce severe destructive Lyme arthritis. Infect. Immun. 63:1400.
16. + T cell interactions. J. Infect. Dis. 171:362.
17. Ma, Y., and J. J. Weiss. 1993. Borrelia burgdorferi stimulate nitric oxide by the cytokine-inducible pathway. Infect. Immun. 61:3843.
18. Tatro, J. B., L. I. Romero, D. Beasley, A. C. Steere, and S. Reichlin. 1994. Borrelia burgdorferi and Escherichia coli lipopolysaccharides induce nitric oxide and IL-6 production in cultured rat brain cells. J. Infect. Dis. 169:1014.
19. Defosse, D. L., and R. C. Johnson. 1992. In vitro and in vivo induction of tumor necrosis factor alpha by Borrelia burgdorferi. Infect. Immun. 60:1109.
20. Habicht, G. S., G. Beck, J. L. Benach, J. L. Coleman, and K. D. Leichtling. 1985. Lyme disease spirochetes induce human and murine interleukin-1 production. J. Immunol. 134:3147.
21. Habicht, G. S., L. I. Katona, and J. L. Benach. 1991. Cytokines and the pathogenesis of neuroborreliosis: Borrelia burgdorferi induces glioma cells to secrete interleukin-6. J. Infect. Dis. 164:568.
22. Kenefick, K. B., L. C. L. Lim, J. D. Adler, F. L. Schmitz, C. J. Czurprynski, and R. F. Schell. 1993. Induction of interleukin-1 release by high and low passage isolates of Borrelia burgdorferi. J. Infect. Dis. 167:1086.
23. Miller, L. C., S. Isa, E. Vannier, K. Georgilis, A. C. Steere, and C. A. Dinarello. 1992. Live Borrelia burgdorferi preferentially activate interleukin-1β gene expression and protein synthesis over the interleukin-1 receptor antagonist. J. Clin. Invest. 90:906.
24. Anguita, J., D. H. Persing, M. Rincon, S. W. Barthold, and E. Fikrig. 1996. Effect of anti-interleukin 12 treatment on murine Lyme borreliosis. J. Clin. Invest. 97:1028.
25. Keane-Myers, A., and S. P. Nickell. 1995. Role of IL-4 and IFN-γ in modulation of immunity to Borrelia burgdorferi in mice. J. Immunol. 155:2020.
26. Matyniak, J. E., and S. L. Reiner. 1995. T helper phenotype and genetic susceptibility in experimental Lyme disease. J. Exp. Med. 181:1251.
27. Keane-Myers, A., C. R. Maliszewski, F. D. Finkelman, and S. P. Nickell. 1996. Recombinant IL-4 treatment augments resistance to Borrelia burgdorferi infections in both normal susceptible and antibody-deficient susceptible mice. J. Immunol. 156:2488.
28. Steimle, V., C. A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science 265:106.
29. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4:167.
30. Fikrig, E., S. W. Barthold, N. Marcantonio, K. Deponte, F. S. Kantor, and R. A. Flavell. 1992. Roles of OspA, OspB, and flagellin in protective immunity to Lyme borreliosis in laboratory mice. Infect. Immun. 60:657.
31. Barthold, S. W., D. S. Beck, G. M. Hansen, G. A. Terwilliger, and K. D. Moody. 1990. Lyme borreliosis in selected strains and ages of laboratory mice. J. Infect. Dis. 162:133.
32. Armstrong, A., S. W. Barthold, D. Persing, and D. Beck. 1992. Carditis in Lyme disease susceptible and resistant strains of laboratory mice infected with Borrelia burgdorferi. Am. J. Trop. Med Hyg. 47:249.
33. Schaible, U. E., M. D. Kramer, R. Wallich, T. Tran, and M. M. Simon. 1991. Experimental Borrelia burgdorferi infection in inbred mouse strains: antibody response and association of H-2 genes with the resistance and susceptibility to development of arthritis. Eur. J. Immunol. 21:2397.